FLOCTAFENINE 200 MG
FLOCTAFENINE : 200 MG · DIN 02244680 · AA PHARMA INC
Health Canada status: DORMANT
What is FLOCTAFENINE?
FLOCTAFENINE 200 MG contains FLOCTAFENINE : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02244680, held by AA PHARMA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as dormant, status dated 24-Jul-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is FLOCTAFENINE used for?
Short-term use in acute pain of mild and moderate severity.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02244680 |
|---|---|
| Brand name | FLOCTAFENINE |
| Generic / active ingredient | FLOCTAFENINE : 200 MG |
| Manufacturer | AA PHARMA INC |
| Strength | 200 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N02BG04 FLOCTAFENINE |
| AHFS class | 28:08.92 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 24-Jul-2020 |
| Original market date | 2001-11-14 00:00:00 |
How is it administered?
Adults: 200 to 400 mg every 6 to 8 hours as required. Maximum daily dose: 1200 mg. Take after a meal or food with a glass of water. Short-term use only.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly specified in provided text (Section 11 is listed in Table of Contents but text ends before section).
How is it supplied?
Bottles of 100 tablets.
Contraindications
Hypersensitivity to drug/NSAIDs; CABG surgery peri-operative setting; 3rd trimester pregnancy; breastfeeding; severe heart failure; ASA-intolerance/asthma; active GI bleeding/ulcer; severe renal/liver impairment.
Warnings and precautions
Serious risk of Cardiovascular (CV) events (MI, stroke) and Gastrointestinal (GI) events (bleeding, ulceration, perforation). Risk of anaphylactoid reactions. May cause hypertension or fluid retention.
What can be used instead?
Other Canadian products sharing ATC code N02BG04 FLOCTAFENINE. 0 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FLOCTAFENINE | 400 MG | TABLET | AA PHARMA INC | DORMANT | DIN 02244681 |
| IDARAC | 200 MG | TABLET | SANOFI-SYNTHELABO CANADA INC | CANCELLED POST MARKET | DIN 02017628 |
| IDARAC | 400 MG | TABLET | SANOFI-SYNTHELABO CANADA INC | CANCELLED POST MARKET | DIN 02017636 |
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.